A systematic review on the effect of bevacizumab in exudative age-related macular degeneration

Graefes Arch Clin Exp Ophthalmol. 2010 Mar;248(3):451-2; author reply 453-4. doi: 10.1007/s00417-009-1249-5. Epub 2009 Dec 10.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aging
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Exudates and Transudates
  • Humans
  • Macular Degeneration / drug therapy*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity / drug effects*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab